Creyon Bio hopes to develop pharmaceuticals “on demand” for patient groups ranging from one person with a rare disease to “millions” of patients with common…
Creyon Bio hopes to develop pharmaceuticals “on demand” for patient groups ranging from one person with a rare disease to “millions” of patients with common…